Comorbidity in bipolar disorder: a framework for rational treatment selection

✍ Scribed by Roger S. McIntyre; Jakub Z. Konarski; Lakshmi N. Yatham

• Publisher: John Wiley and Sons
• Year: 2004
• Tongue: English
• Weight: 172 KB
• Volume: 19
• Category: Article
• ISSN: 0885-6222
• DOI: 10.1002/hup.612

✦ Synopsis

Abstract

Bipolar disorders are heterogeneous disorders often requiring multimodality treatment. The expanding pharmacopeia for bipolar disorders invites the need for a treatment framework that both recognizes and anticipates the multidimensionality and comorbidity of the illness. No available neurotherapeutic agent is singularly efficacious for the complete mélange of bipolar symptomatology. An apparent paradox has emerged in the management of bipolar disorder; whilst results from rigorous controlled monotherapy trials suggest that a disparate assortment of neurotherapeutic agents are efficacious in distinct phases of bipolar disorder, the majority of tertiary‐treated bipolar patients receive polypharmacotherapeutic regimens. The evidentiary base for polypharmacotherapy is sparse and has recently become an area of active research focus. In the interim, clinicians are encouraged to invoke an organizational schema for the treatment of bipolar disorder that considers the spectrum of effectiveness of putative and established mood stabilizers. This schema should be further informed by the treatment data for comorbid and accessory conditions. The authors propose a schema to provide the impetus for further work in the area. Copyright © 2004 John Wiley & Sons, Ltd.